Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LABT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
LABT
Lakewood-Amedex Biotherapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
LABT
Lakewood-Amedex Biotherapeutics Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LABT
with
LLY
No shared trading history for LABT and LLY.
Shared co-movers: not yet measured (LABT).
LABT, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
LABT
Lakewood-Amedex Biotherapeutics Inc.
Change
0.39
▼
−27.80%
Mkt cap
$271,743
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,363.13
▼
−0.12%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
LABT
Lakewood-Amedex Biotherapeutics Inc.
vs
LLY
ELI Lilly & Co
0.39
▼
−27.80%
Price
1,363.13
▼
−0.12%
$271,743
Mkt cap
$1.2T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
LABT
0.39
▼
−27.80%
vs
LLY
1,363.13
▼
−0.12%
Regular session
Nov 6 '26